Clovis Oncology to Announce Third Quarter 2018 Financial Results and Host Webcast Conference Call on October
30
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its third quarter 2018 financial results on Tuesday, October 30, 2018, after
the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m.
ET to discuss the company’s results in greater detail.
The conference call is being webcast and can be accessed from the Clovis Oncology website at
www.clovisoncology.com. A replay of the webcast will be available for 30 days.
Conference Call Details
Clovis will hold a conference call to discuss third quarter 2018 results on October 30 at 4:30 p.m. ET. The conference call will
be simultaneously webcast on the Company’s web site at
www.clovisoncology.com, and archived for future review. Dial-in numbers for the conference call are as follows: US participants
866.393.4306, International participants 734.385.2616; conference ID: 5885294.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets
of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has
additional offices in San Francisco and Oakland, California and Cambridge, UK. Please visit
clovisoncology.com for more information.
Clovis Investor Contacts:
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20181016005030/en/